Skip to primary navigation Skip to main content
Buffalo Local Index
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Local Stocks
Axovant Sciences Ltd (NQ: AXON)
2.100 USD  +0.030 (+1.45%)
Official Closing Price  /  Updated: 4:47 PM EDT, Aug 14, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 740,631
Open 2.100
Bid (Size) 2.010 (4)
Ask (Size) 2.080 (20)
Prev. Close 2.070
Today's Range 2.045 - 2.140
52wk Range 1.020 - 27.98
Shares Outstanding 107,788,074
Dividend Yield N/A
Performance
YTD
-60.45%
-60.45%
1 Month
-14.63%
-14.63%
3 Month
+79.49%
+79.49%
6 Month
+16.02%
+16.02%
1 Year
-90.04%
-90.04%
Top News
More News
Axovant Announces First Fiscal Quarter 2018 Financial Results and Corporate Update
Axovant Sciences (NASDAQ:AXON) today announced corporate updates and financial results for its first fiscal quarter ended June 30, 2018. Read More
from GlobeNewswire News Releases
Axovant Announces Global Licensing Agreement for AXO-AAV-OPMD Program for Treatment of Oculopharyngeal Muscular Dystrophy and Broader Platform Collaboration with Benitec Biopharma
Axovant Sciences (NASDAQ:AXON) today announced that it has licensed exclusive global rights to an investigational Silence-and-Replace gene therapy program from Benitec Biopharma for the treatment of... Read More
from GlobeNewswire News Releases
More News
Read More
Axovant to Present at First Annual Roivant Pipeline Day
from GlobeNewswire News Releases
How The Parts Add Up: IBB Targets $141
category ETFs
from ETF Channel
3 Biotech Stocks That Soared This Week: Are They Buys?
category ZGNX , Market News , AXON , and 2 more.
from Motley Fool
3 Gene Therapy Stocks Investors Can Bet On In Rest Of 2018
category Stocks / Equities , Pharma/Biotech
from Blogs - TalkMarkets
The Sad Truth: This Biotech Investing Strategy Almost Always Works
category LLY , Market News , ESALY , and 2 more.
from Motley Fool
Analysts Predict 24% Upside For IBB
category ETFs
from ETF Channel
Jul 8 Above the 40 – Bears Overstay Their Welcome
from Blogs - TalkMarkets
Here's Why Axovant Sciences Fell as Much as 21.3% Today
category AXON , Market News
from Motley Fool
Why Xunlei, Griffon, and Axovant Sciences Slumped Today
category GFF , AXON , Market News , and 1 more.
from Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.